Compare AMRX & NHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMRX | NHI |
|---|---|---|
| Founded | 2002 | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 3.7B |
| IPO Year | N/A | 1991 |
| Metric | AMRX | NHI |
|---|---|---|
| Price | $11.98 | $78.32 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 5 |
| Target Price | $13.25 | ★ $84.80 |
| AVG Volume (30 Days) | ★ 1.7M | 168.9K |
| Earning Date | 10-30-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 4.70% |
| EPS Growth | N/A | ★ 8.88 |
| EPS | 0.02 | ★ 3.17 |
| Revenue | ★ $2,934,959,000.00 | $357,572,000.00 |
| Revenue This Year | $9.99 | $5.50 |
| Revenue Next Year | $6.67 | $11.38 |
| P/E Ratio | $745.76 | ★ $24.73 |
| Revenue Growth | ★ 9.50 | 8.40 |
| 52 Week Low | $6.69 | $65.13 |
| 52 Week High | $12.68 | $80.56 |
| Indicator | AMRX | NHI |
|---|---|---|
| Relative Strength Index (RSI) | 55.77 | 54.19 |
| Support Level | $11.83 | $77.74 |
| Resistance Level | $12.25 | $79.82 |
| Average True Range (ATR) | 0.33 | 1.30 |
| MACD | -0.08 | -0.08 |
| Stochastic Oscillator | 44.31 | 29.51 |
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.
National Health Investors Inc is a housing and medical facility REIT. The company operates through two reportable segments, i.e., Real Estate Investments and Senior Housing Operating Portfolio (SHOP). The Real Estate Investments segment, which generates maximum revenue, consists of real estate investments and leases, mortgages, and other notes receivables in independent living facilities, assisted living facilities, entrance fee communities, senior living campuses, skilled nursing facilities, and a hospital. The SHOP segment is comprised of two ventures that own the operations of independent living facilities. The company's revenues are derived in the form of rental income, mortgage and other notes receivable interest income, and resident fees and services.